4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-429073
Director bought 35,714 shares at $27.28 ($974,278)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PAUL STEVEN M Director | 2026-10-22 | Purchase | +35,714 | $27.28 | $974,278 | 77,380 | I |
| Open-market purchases · 35,714 sh · avg $27.28 · $974,278 | |||||||
Loading xslF345X06/ownership.xml…